Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04542070 |
|---|---|
| Brief Title: | A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed (SOLAR) |
| First Submitted : | September 1, 2020 |
| First Submitted that Met QC Criteria : | September 1, 2020 |
| First Posted : | September 9, 2020 |
| Results First Submitted : | July 12, 2023 |
| Results First Posted with QC Comments : | August 3, 2023 |
| Results First Submitted that Met QC Criteria : | August 23, 2023 |
| Results First Posted : | September 13, 2023 |
| Last Update Submitted that Met QC Criteria : | August 23, 2023 |
| Last Update Posted : | September 13, 2023 |